1. Carmichael, A. Cytomegalovirus and the eye. Eye Lond. Engl. 26:237–240, 2012
2.Zuhair, M.; Smit, G.S.A.;Wallis, G.; Jabbar, F.; Smith, C.; Devleesschauwer, B.; Griths, P. Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev. Med. Virol. 2019, 29, e2034.
3.Marchesi F, Pimpinelli F, Ensoli F, Mengarelli A. Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant. Hematol Oncol. 2018;36(2):381‐391
4. Fuller R, Strauss D, Steinberg A, Rana M, Keyzner A, Dunn D, Jacobs SE. A lymphoma patient with Cytomegalovirus retinitis and post-autologous hematopoietic cell transplantation immune reconstitution uveitis: A case report and review of the literature. Transpl Infect Dis. 2019 Aug;21(4):e13099.
5. Carbone J. The immunology of posttransplant CMV infection: potential effect of CMV immunoglobulins on distinct components of the immune response to CMV. Transplantation. 2016;100:S11‐S18
6. Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol.2012 Jun;153(6):1016-24.
7. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140(3):509-16.
8. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92(4):467-71.
9. Pollard RB, Egbert PR, Gallagher JG, Merigan TC: Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. Ann InternMed 1980;93: 655–664.
10. Nasir MA, Jaffe GJ. Cytomegalovirus retinitis associated with Hodgkin's disease. Retina. 1996;16(4):324-7
11. Kang HM. CMV retinitis in patients with DLBCL. J Retina 2017;2:97-100
12.Tyagi M, Ambiya V, Mathai A, Narayanan R. Atypical cytomegalovirus retinitis in non‐Hodgkin's lymphoma. BMJ Case Rep.2015;2015:bcr2015210812
13.Pathanapitoon K, Tesavibul N, Choopong P, Boonsopon S, Kongyai N, Ausayakhun S, Kunavisarut P, Rothova A. Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection. JAMA Ophthalmol. 2013 May;131(5):638-45.
14. Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM. Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms. 2019 Dec 28;8(1). pii: E55.
15. Ho M, Invernizzi A, Zagora S, Tsui J, Oldani M, Lui G, McCluskey P, Young AL. Presenting Features, Treatment and Clinical Outcomes of Cytomegalovirus Retinitis: Non-HIV Patients Vs HIV Patients. Ocul Immunol Inflamm. 2019 Jun 5:1-8.
16. DerzkoDzulynsky LA, Berger AR, Berinstein NL. Cytomegalovirus retinitis and lowgrade nonHodgkin’s lymphoma: case report and review of the literature. Am J Hematol 1998;57:228–32.
17. Chawla R, Venkatesh P, Garg SP, Mandal S, Tewari HK. Cytomegalovirus retinitis in a patient with non-Hodgkin's lymphoma: a diagnostic dilemma. Eur J Ophthalmol. 2005 Jan-Feb;15(1):153-7.
18. Zhao Y, Shao Q, Peng G. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol. 2020 Jan;17(1):27-35.
19. Xia A, Zhang Y, Xu J, Yin T, Lu XJ. T Cell Dysfunction in Cancer Immunity and Immunotherapy. Front Immunol. 2019 Jul 19;10:1719.
20. Karavellas MP, Azen SP, MacDonald JC, Shufelt CL, Lowder CY, Plummer DJ, Glasgow B, Torriani FJ, Freeman WR. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina. 2001;21(1):1-9.
21. Jacobsen T, Sifontis N. Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection. American Journal of Health-System Pharmacy. 2010 Sep 1;67(17):1417-25
22. Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group. Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. Am J Ophthalmol. 2011 Oct;152(4):628-637.e1